Prior Auth for Obesity Drugs; New Dietary Guidelines? Bariatric Surgery vs GLP-1s

Bariatric surgery better than GLP-1 drugs for weight loss : ASMBS study

Prior Auth for Obesity Drugs; New Dietary Guidelines? Bariatric Surgery vs GLP-1s

(MedPage Today) -- The American Medical Association's House of Delegates passed an Endocrine Society resolution that aims to improve access to weight-loss medications by reducing the burden of prior authorization. Patients on Eli Lilly's investigational...

Self-esteem surges within one year of BMS

Self-esteem scores more than doubled within one year of Bariatric and metabolic surgery (BMS) according to a new study presented at the American Society for Metabolic and Bariatric Surgery (ASMBS) 2025 Annual Scientific Meeting.Researchers from Geisinger Medical Center found that after bariatric surgery self-esteem scores rose to 77.5 from 33.6 – a more than 40-point increase. The higher the score on a scale from 0 to 100, the higher the level o…

Next-Generation Obesity Treatments Take Center Stage at ADA

Research symposia focus on new combinations and medication formulations for both obesity and type 2 diabetes, as well as new approaches for type 1 diabetes and much more. Medscape Medical News

New Tirzepatide Access and Pricing Through Self-Pay Options

Eli Lilly is expanding access to tirzepatide, a groundbreaking GLP-1 medication for weight management, offering more affordable options for obesity treatment.